Skip to main content
. 2014 Jan 1;23(1):38–43. doi: 10.1089/jwh.2012.4241

Table 1.

Baseline Characteristics of Consistent Oral Contraceptive Users by Body Mass Index Group

Variable Normal weight (n=96) Obese (n=54) p1
Height (cm)
164.1±6.4
163.8±6.6
0.83
Weight (kg)
59.6±6.7
91.9±9.3
<0.01
BMI (kg/m2)
22.1±1.5
34.2±2.6
<0.01
Percent body fat (%)2
29.2±3.7
47.4±3.5
<0.01
Fat mass (kg)2
17.6±3.7
43.8±6.9
<0.01
Fat free mass (kg)2
42.1±3.9
48.2±4.0
<0.01
Total body water (kg)2
29.4±2.9
36.8±3.6
<0.01
Age
24.7±4.5
25.7±4.0
0.17
Race/ethnicity
 Hispanic
19 (19.8)
19 (35.2)
<0.01
 Non-Hispanic black
30 (31.3)
23 (42.6)
 
 Non-Hispanic white
33 (34.4)
11 (20.4)
 
 Non-Hispanic Asian
14 (14.6)
1 (1.9)
 
Education
 Less than a bachelor's degree
43 (44.8)
31 (57.4)
0.14
 Bachelor's degree or more
53 (55.2)
23 (42.6)
 
Previous pregnancy
 Yes
29 (30.2)
28 (51.9)
<0.01
 No
67 (69.8)
26 (48.2)
 
Previous birth
 Yes
9 (9.4)
20 (37.0)
<0.01
 No
87 (90.6)
34 (63.0)
 
Using OC at enrollment
 Yes
22 (22.9)
12 (22.2)
0.92
 No
74 (77.1)
42 (77.8)
 
Smokes cigarettes
 Yes
11 (11.5)
10 (18.5)
0.23
 No
85 (88.5)
44 (81.5)
 
OC dose
 20 μg EE/100 μg LNG
47 (49.0)
23 (42.6)
0.45
 30 μg EE/150 μg LNG 49 (51.0) 31 (57.4)  

Values are shown as mean±standard deviation or n (%).

1

t-test for continuous variables and chi-square test or Fisher's exact test for categorical variables.

2

Baseline measurements for these variables were unavailable for one normal weight participant due to machine malfunction.

EE, ethinyl estradiol; LNG, levonorgestrel; OC, oral contraceptive.